Global Medical Devices Market was valued at USD 458.3 billion in 2022 and is projected to reach USD 801.4 billion by 2031, growing at a CAGR of 6.3% during the Forecast Period 2023 to 2023.
Rapidly Growing sedentary lifestyles and irregularity in health checkups in both developing and developed countries has led to a significant increase in the prevalence of obesity, neuro-based disorders, heart disease, diabetes, and other lifestyle-related chronic diseases. According to the American Heart Association, cardiovascular illnesses caused 17.6 million deaths in 2016 and are expected to reach over 23.6 million by 2030, highlighting the urgent need for medical intervention. As a result, the demand for medical devices is at a significant rate, and the growing prevalence of cancer is having a positive impact on the market's growth. Early detection of cancer is crucial for better treatment outcomes and longer life expectancy, leading to the increased popularity of medical imaging tests, screening mammography, and other cancer prevention screening tests.
With the significant increase in diabetes prevalence worldwide, glucometers are frequently used at home to check blood sugar levels in the global medical devices market. According to the World Health Organization, diabetes affected 8.5% of persons aged 18 and above globally, causing around 1.5 million direct deaths in the recent year. In line with this, several medical device manufacturers are focusing on developing simple and hassle-free medical devices for home usage, such as Abbott Laboratories' Freestyle Libre System, which eliminates the need for routine glucose finger-prick testing.
Advancements in medical device technology including enhanced connectivity and real-time accessibility are boosting overall market growth. The emergence of 3D printing in the healthcare industry has had a tremendous impact on the medical device industry, allowing for design modifications without the use of additional equipment and the production of tailored devices for patients.
To Get more Insights, Request A Free Sample
With the rapid advancements in technology, medical devices have become more sophisticated and effective. The development of innovative and advanced medical devices such as minimally invasive surgical instruments, wearable medical devices, and robotic surgical systems have contributed to the growth of the medical devices market. These technologies have enabled healthcare providers to offer improved diagnosis, treatment, and patient care, which has resulted in increased demand for medical devices.
The aging population is a significant driver of the medical devices market. The aging population requires more medical attention and care, leading to an increased demand for medical devices. In addition, the rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases has increased the demand for medical devices such as insulin pumps, chemotherapy devices, and implantable devices such as pacemakers and defibrillators. Aging population and increasing chronic diseases: The World Health Organization estimates that the global population aged 60 years and older will nearly double from 900 million in 2015 to about 2 billion in 2050. The rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases has also contributed to the growth of the medical devices market. For example, according to the American Diabetes Association, in 2020, 34.2 million Americans had diabetes, and this number is projected to rise to 54.9 million by 2030.
The medical devices market is highly regulated, and the regulations can vary significantly across different countries. The approval process for medical devices can be lengthy and costly, which can hinder the growth of the market. Stringent regulations can also increase the cost of manufacturing medical devices, making them more expensive for consumers. In addition, the regulations can limit innovation and the development of new medical devices. Companies must ensure that their products comply with regulations, which can limit their ability to introduce new and innovative medical devices to the market.
Patient monitoring devices have the highest CAGR of 7.3% among all products in the global medical devices market. Due to their ease of use and real-time monitoring capabilities, patient monitoring devices are increasingly used in hospitals and at home, particularly during the COVID-19 pandemic. Wireless patient monitoring, anesthetic systems, pulse oximeters, capnography monitors, and other devices are examples of patient monitoring devices available in the market. They help in monitoring vital signs such as heart rate, blood pressure, oxygen saturation, and respiratory rate, among others, and can also be used to monitor patients with chronic conditions, such as diabetes and hypertension.
In addition, a survey by Emergo by UL found that 49% of medical device companies listed regulatory compliance as one of their top challenges in 2022.
Application Segments:
The respiratory category has the highest CAGR in the global medical devices market due to the increasing prevalence of chronic respiratory diseases. Medical devices in this category include nebulizers, ventilators, CPAP machines, and other devices that help patients with respiratory issues breathe easier. The cardiovascular category also holds a significant share in the medical devices market and includes devices such as pacemakers, stents, and defibrillators, among others.
End User Segments:
Hospitals and surgical centers are the largest end users of medical devices, accounting for around 51% of shareholding in 2022. The increasing healthcare expenditure and the development of healthcare organizations have led to the growth of hospitals and surgical centers, making them key end users of medical devices. Other end users in the medical devices market include diagnostic centers, home healthcare settings, and ambulatory surgical centers.
To Understand More About this Research: Request A Free Sample
The Asia-Pacific medical devices market to grow at the highest CAGR of 7.1% throughout the forecast period. Wherein, China is the largest contributor to the regional market, indicating that the demand for the product or service is significantly high in this country. This can be attributed to the large population in China and the growing middle class, which is becoming increasingly affluent and able to afford higher-quality products and services. Additionally, China has been investing heavily in infrastructure development, which has created opportunities for the growth of the market.
Japan follows China in terms of market share, indicating that there is also significant demand for the product or service in this country. Japan is known for its highly developed economy and technological advancements, which have created opportunities for the growth of the market.
The Asia-Pacific market is also being driven by government policies aimed at promoting economic growth. China, for example, has launched a series of initiatives aimed at boosting innovation and entrepreneurship, including the "Made in China 2025" plan and the "Internet Plus" policy. Japan, meanwhile, has implemented a range of policies aimed at revitalizing its economy, including efforts to promote innovation and support small and medium-sized enterprises.
By Product
By Application
By End-User
By Geography
| Report Attribute | Details |
|---|---|
| Market Size Value in 2022 | US$ 458.3 Bn |
| Expected Revenue in 2031 | US$ 801.4 Bn |
| Historic Data | 2018-2021 |
| Base Year | 2022 |
| Forecast Period | 2023-2031 |
| Unit | Value (USD Bn) |
| CAGR | 6.3% |
| Segments covered | By Product, By Application, By End-User, By Region |
| Key Companies | 3M Co., Abbott Laboratories, Allergan Inc., Baxter International Inc., Bayer, Becton, Dickinson and Co., Boston Scientific Corp., Cardinal Health Inc., Covidien plc, Cryolife Inc., Danaher, Depuy Synthes, Endologix, Inc., Essilor International SA, Fresenius Medical Care AG & Co. KGAA, GE Healthcare, Getinge Ab, Johnson & Johnson, Koninklijke Philips NV, Medtronic Inc., Novartis AG, Olympus Corp., Roche Diagnostics, Siemens Healthcare, Smith & Nephew PLC, Smiths Medical, St. Jude Medical Inc., Stryker Corp., Terumo Corp., Thermo Fisher Scientific, Zimmer Holdings Inc., Other Prominent Players |
| Customization Scope | Get your customized report as per your preference. Ask for customization |
The medical device industry is majorly dominated by small-scale companies and consist of very few big players. Although, industry is facing an increasing competition from unrelated industries with technological innovation that will outpace clinical innovation in the long-term.
Global medical device market generated a revenue of US$ 458.3 Bn in 2022.
The market is growing at a CAGR of 6.3% during the forecast period 2023-2031.
North America is dominating the global medical device industry followed by Asia-Pacific.
The report gives a comprehensive market analysis and forecast on the basis of various factors at different segment level. Some of the key segments are product, application, end user and region. These segments are further categorized into sub-segments to study the market extensively.
The report includes detailed profiles of 31 companies, under various heads such as Business description, strategic outlook, product portfolio, financial details, recent developments, business segmentations and regional segmentations.
Yes, the report offers a detailed study of COVID-19 impact on the industry that include analysis on different levels- Optimistic Outlook, Pessimistic Outlook, Astute Analysis and Pre-COVID Outlook.
Yes, there is a dedicated chapter that explains about regulatory landscape of the industry.
Medtronics, Johnson and Johnson, Abbott and GE Healthcare are the major shareholders in the global medical devices market and study shows that cumulative market share of the 15 major players is close to 45%, hence the market is fragmented in nature.
Threat of new entrants is moderate in the medical device market, due to high capital investment in terms of medical devices development cost, R&D setup cost, legal cost, marketing expense, distribution cost, and other cost. Medical device industry requires huge distribution networks and supply chain management to run the operations, thus new entrants in the market face tough competition from the existing competitors in the industry.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.
SPEAK TO AN ANALYST
.png)
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
| Report ID: AA1021097 
.svg)
